Radiotherapy as a means to increase the efficacy of T-cell therapy in solid tumors

Chimeric antigen receptor (CAR)-T cells have demonstrated significant improvements in the treatment of refractory B-cell malignancies that previously showed limited survival. In contrast, early-phase clinical studies targeting solid tumors have been disappointing. This may be due to both a lack of s...

Descripción completa

Detalles Bibliográficos
Autores principales: Laurent, Pierre-Antoine, Morel, Daphne, Meziani, Lydia, Depil, Stephane, Deutsch, Eric
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9788698/
https://www.ncbi.nlm.nih.gov/pubmed/36567802
http://dx.doi.org/10.1080/2162402X.2022.2158013

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9788698/
https://www.ncbi.nlm.nih.gov/pubmed/36567802
http://dx.doi.org/10.1080/2162402X.2022.2158013

Ejemplares similares